According to the Zhitong Finance App, Sinopharm Technology Co., Ltd. (08156.HK) announced its annual results for the year ended June 30, 2026, with revenue of HK$45.82 million, a year-on-year decrease of 25.58%. The loss attributable to the company owner was HK$9.142 million, a significant increase of 954.44% over the previous year. Loss per share was HK1.97 cents.

Disclaimer:Webull uses external vendor Google Translation Service for news translations where we endeavour to ensure these are correct, however, we recommend that you please double-check this information accordingly. Webull is not responsible for translation errors or issues.